会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • HEDGEHOG PATHWAY SIGNALING INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF
    • HEDGEHOG PATHWAY信号抑制剂及其治疗应用
    • WO2014113191A1
    • 2014-07-24
    • PCT/US2013/077305
    • 2013-12-20
    • ZHANG, Xiaohu
    • ZHANG, Xiaohu
    • A61K31/395
    • C07D487/04C07D471/04C07D498/04C07D513/04
    • The hedgehog (Hh) signaling pathway is a pathway which regulates patterning, growth and cell migration during embryonic development, but in adulthood is limited to tissue maintenance and repair. Mutational inactivation of the inhibitory pathway components leads to constitutive ligand-independent activation of the Hh signaling pathway, results in cancers such as basal cell carcinoma and medulloblastoma. Ligand-dependent activation of Hh signaling is involved in prostate cancer, pancreatic cancer, breast cancer and blood cancers. Therefore, inhibition of the aberrant Hh signaling represents a promising approach toward novel anticancer therapy. The invention provides novel molecules of formula I that inhibit hedgehog pathway signaling and provides therapeutic applications for the treatment of malignancies (basal cell carcinoma, medulloblastoma, glioblastoma, non-small cell lung cancer, prostate cancer, pancreatic cancer, blood cancers, mesenchymal cancers, etc.), prevention of tumor regrowth, sensitization of radio-chemo therapies, and other diseases (inflammation, fibrosis and immune disorders).
    • 刺猬(Hh)信号通路是调控胚胎发育过程中的图案,生长和细胞迁移的途径,但成年期限于组织维持和修复。 抑制性途径组分的突变失活导致Hh信号通路的组成型配体非依赖性激活,导致癌症如基底细胞癌和成神经管细胞瘤。 Hh信号传导的配体依赖性激活涉及前列腺癌,胰腺癌,乳腺癌和血液癌。 因此,抑制异常Hh信号代表了一种有希望的新型抗癌治疗方法。 本发明提供抑制刺猬蛋白通路信号传导的新型分子式I,并提供用于治疗恶性肿瘤(基底细胞癌,成神经管细胞瘤,成胶质细胞瘤,非小细胞肺癌,前列腺癌,胰腺癌,血癌,间充质癌, 等等),预防肿瘤再生长,放射化学疗法的敏化和其他疾病(炎症,纤维化和免疫疾病)。